Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infectionGerrit Jan Weverling, Peter Reiß, Ole Kirk et al.|The Lancet|1999Cited by 223
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) StudyLene Ryom, Jens Lundgren, Peter Reiß et al.|The Journal of Infectious Diseases|2019Cited by 20